Skip to main content
Top
Published in: AIDS and Behavior 3/2017

01-03-2017 | Original Paper

Residential Eviction and Risk of Detectable Plasma HIV-1 RNA Viral Load Among HIV-Positive People Who Use Drugs

Authors: Mary Clare Kennedy, Thomas Kerr, Ryan McNeil, Surita Parashar, Julio Montaner, Evan Wood, M.-J. Milloy

Published in: AIDS and Behavior | Issue 3/2017

Login to get access

Abstract

We examined the relationship between residential eviction and exhibiting detectable plasma HIV-1 RNA viral load (VL) among a prospective cohort of antiretroviral therapy (ART)-exposed HIV-seropositive people who use illicit drugs (PWUD) in Vancouver, Canada. We used multivariable generalized estimating equations to estimate the effect of residential eviction on detectable VL and examine ART adherence as a mediating variable. Between June 2007 and May 2014, 705 ART-exposed participants were included in the study, among whom 500 (70.9 %) experienced at least one period of detectable VL. In a time-updated multivariable model, eviction independently increased the odds of detectable VL among those who were homeless [adjusted odds ratio (AOR) = 2.25; 95 % confidence interval (CI) 1.18–4.29] as well as not homeless (AOR = 1.76; 95 % CI 1.17–2.63) post eviction. The results of mediation analyses suggest that this association was mediated by incomplete ART adherence. These findings suggest the need for further development and evaluation of interventions to prevent evictions and promote ART adherence among PWUD facing eviction.
Literature
1.
go back to reference Wood E, Hogg RS, Lima V, et al. Highly active antiretroviral therapy and survival in HIV-infected injection drug users. JAMA. 2008;300(5):550–4.CrossRefPubMed Wood E, Hogg RS, Lima V, et al. Highly active antiretroviral therapy and survival in HIV-infected injection drug users. JAMA. 2008;300(5):550–4.CrossRefPubMed
2.
go back to reference Wood E, Hogg RS, Yip B, Harrigan PR, Montaner JSG. Why are baseline HIV RNA levels 100,000 copies/mL or greater associated with mortality after the initiation of antiretroviral therapy? J Acquir Immune Defic Syndr. 2005;38(3):289–95.PubMed Wood E, Hogg RS, Yip B, Harrigan PR, Montaner JSG. Why are baseline HIV RNA levels 100,000 copies/mL or greater associated with mortality after the initiation of antiretroviral therapy? J Acquir Immune Defic Syndr. 2005;38(3):289–95.PubMed
5.
go back to reference Robbins GK, Johnson KL, Chang Y, et al. Predicting virologic failure in an HIV clinic. Clin Infect Dis. 2010;50(5):779–86.PubMedPubMedCentral Robbins GK, Johnson KL, Chang Y, et al. Predicting virologic failure in an HIV clinic. Clin Infect Dis. 2010;50(5):779–86.PubMedPubMedCentral
6.
go back to reference Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med. 1999;131(2):81–7.CrossRefPubMed Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med. 1999;131(2):81–7.CrossRefPubMed
7.
go back to reference Lucas GM, Cheever LW, Chaisson RE, Moore RD. Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr. 2001;27(3):251–9.CrossRefPubMed Lucas GM, Cheever LW, Chaisson RE, Moore RD. Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr. 2001;27(3):251–9.CrossRefPubMed
8.
go back to reference Palepu A, Tyndall M, Yip B, O’Shaughnessy MV, Hogg RS, Montaner JSG. Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use. J Acquir Immune Defic Syndr. 2003;32(5):522–6.CrossRefPubMed Palepu A, Tyndall M, Yip B, O’Shaughnessy MV, Hogg RS, Montaner JSG. Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use. J Acquir Immune Defic Syndr. 2003;32(5):522–6.CrossRefPubMed
9.
go back to reference Chander G, Himelhoch S, Fleishman JA, et al. HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use. AIDS Care. 2009;21(5):655–63.CrossRefPubMedPubMedCentral Chander G, Himelhoch S, Fleishman JA, et al. HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use. AIDS Care. 2009;21(5):655–63.CrossRefPubMedPubMedCentral
10.
go back to reference Weber R, Huber M, Rickenbach M, et al. Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study. HIV Med. 2009;10(7):407–16.CrossRefPubMed Weber R, Huber M, Rickenbach M, et al. Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study. HIV Med. 2009;10(7):407–16.CrossRefPubMed
11.
go back to reference Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376(9738):367–87.CrossRefPubMedPubMedCentral Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376(9738):367–87.CrossRefPubMedPubMedCentral
12.
go back to reference Strathdee SA, Hallett TB, Bobrova N, et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet. 2010;376(9737):268–84.CrossRefPubMed Strathdee SA, Hallett TB, Bobrova N, et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet. 2010;376(9737):268–84.CrossRefPubMed
13.
go back to reference Milloy M-J, Marshall BDL, Kerr T, et al. Social and structural factors associated with HIV disease progression among illicit drug users: a systematic review. AIDS. 2012;26(9):1049–63.CrossRefPubMedPubMedCentral Milloy M-J, Marshall BDL, Kerr T, et al. Social and structural factors associated with HIV disease progression among illicit drug users: a systematic review. AIDS. 2012;26(9):1049–63.CrossRefPubMedPubMedCentral
14.
go back to reference Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of HIV risk among injecting drug users. Soc Sci Med. 2005;61(5):1026–44.CrossRefPubMed Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of HIV risk among injecting drug users. Soc Sci Med. 2005;61(5):1026–44.CrossRefPubMed
15.
go back to reference Rhodes T. The, “risk environment”: a framework for understanding and reducing drug-related harm. Int J Drug Policy. 2002;13(2):85–94.CrossRef Rhodes T. The, “risk environment”: a framework for understanding and reducing drug-related harm. Int J Drug Policy. 2002;13(2):85–94.CrossRef
16.
go back to reference Milloy MJ, Kerr T, Buxton J, et al. Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis. 2011;203(9):1215–21.CrossRefPubMedPubMedCentral Milloy MJ, Kerr T, Buxton J, et al. Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis. 2011;203(9):1215–21.CrossRefPubMedPubMedCentral
17.
go back to reference Piketty C, Castiel P, Giral P, et al. Lack of legal income is strongly associated with an increased risk of AIDS and death in HIV-infected injecting drug users. AIDS Care. 1999;11(4):429–36.CrossRefPubMed Piketty C, Castiel P, Giral P, et al. Lack of legal income is strongly associated with an increased risk of AIDS and death in HIV-infected injecting drug users. AIDS Care. 1999;11(4):429–36.CrossRefPubMed
18.
go back to reference Knowlton A, Arnsten J, Eldred L, et al. Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug users. J Acquir Immune Defic Syndr. 2006;41(4):486–92.CrossRefPubMed Knowlton A, Arnsten J, Eldred L, et al. Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug users. J Acquir Immune Defic Syndr. 2006;41(4):486–92.CrossRefPubMed
19.
20.
go back to reference Palepu A, Milloy M-J, Kerr T, Zhang R, Wood E. Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users. J Urban Health. 2011;88(3):545–55.CrossRefPubMedPubMedCentral Palepu A, Milloy M-J, Kerr T, Zhang R, Wood E. Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users. J Urban Health. 2011;88(3):545–55.CrossRefPubMedPubMedCentral
21.
go back to reference Knowlton AR, Arnsten JH, Eldred LJ, et al. Antiretroviral use among active injection-drug users: the role of patient-provider engagement and structural factors. AIDS Patient Care STDS. 2010;24(7):421–8.CrossRefPubMedPubMedCentral Knowlton AR, Arnsten JH, Eldred LJ, et al. Antiretroviral use among active injection-drug users: the role of patient-provider engagement and structural factors. AIDS Patient Care STDS. 2010;24(7):421–8.CrossRefPubMedPubMedCentral
22.
go back to reference Milloy M-J, Kerr T, Bangsberg DR, et al. Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian setting. AIDS Patient Care STDS. 2012;26(1):60–7.CrossRefPubMedPubMedCentral Milloy M-J, Kerr T, Bangsberg DR, et al. Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian setting. AIDS Patient Care STDS. 2012;26(1):60–7.CrossRefPubMedPubMedCentral
23.
go back to reference Kidder DP, Wolitski RJ, Campsmith ML, Nakamura GV. Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV/AIDS. Am J Public Health. 2007;97(12):2238–45.CrossRefPubMedPubMedCentral Kidder DP, Wolitski RJ, Campsmith ML, Nakamura GV. Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV/AIDS. Am J Public Health. 2007;97(12):2238–45.CrossRefPubMedPubMedCentral
24.
go back to reference Lieb S, Brooks RG, Hopkins RS, et al. Predicting death from HIV/AIDS: a case-control study from Florida public HIV/AIDS clinics. J Acquir Immune Defic Syndr. 2002;30(3):351–8.CrossRefPubMed Lieb S, Brooks RG, Hopkins RS, et al. Predicting death from HIV/AIDS: a case-control study from Florida public HIV/AIDS clinics. J Acquir Immune Defic Syndr. 2002;30(3):351–8.CrossRefPubMed
25.
go back to reference Chum A. The impact of gentrification on residential evictions. Urban Geogr. 2015;2015:1–16. Chum A. The impact of gentrification on residential evictions. Urban Geogr. 2015;2015:1–16.
26.
go back to reference Carey CA. No second chance: people with criminal records denied access to public housing. U Tol L Rev. 2004;2005(36):545. Carey CA. No second chance: people with criminal records denied access to public housing. U Tol L Rev. 2004;2005(36):545.
27.
go back to reference Dickson-Gomez JB, Convey M, Hilario H, Corbett AM, Weeks M. Structural and personal factors related to access to housing and housing stability among urban drug users in Hartford, Connecticut. Contemp Drug Probl. 2008;35(1):115–52. Dickson-Gomez JB, Convey M, Hilario H, Corbett AM, Weeks M. Structural and personal factors related to access to housing and housing stability among urban drug users in Hartford, Connecticut. Contemp Drug Probl. 2008;35(1):115–52.
28.
go back to reference Dickson-Gomez JB, Cromley E, Convey M, Hilario H. How much choice is there in housing choice vouchers? Neighborhood risk and free market rental housing accessibility for active drug users in Hartford, Connecticut. Subst Abuse Treat Prev Policy. 2009;4(1):5.CrossRefPubMedPubMedCentral Dickson-Gomez JB, Cromley E, Convey M, Hilario H. How much choice is there in housing choice vouchers? Neighborhood risk and free market rental housing accessibility for active drug users in Hartford, Connecticut. Subst Abuse Treat Prev Policy. 2009;4(1):5.CrossRefPubMedPubMedCentral
29.
go back to reference Phinney R, Danziger S, Pollack HA, Seefeldt K. Housing instability among current and former welfare recipients. Am J Public Health. 2007;97(5):832–7.CrossRefPubMedPubMedCentral Phinney R, Danziger S, Pollack HA, Seefeldt K. Housing instability among current and former welfare recipients. Am J Public Health. 2007;97(5):832–7.CrossRefPubMedPubMedCentral
30.
go back to reference Cooper HLF, Wodarski S, Cummings J, et al. Public housing relocations in Atlanta, Georgia, and declines in spatial access to safety net primary care. Health Place. 2012;18(6):1255–60.CrossRefPubMedPubMedCentral Cooper HLF, Wodarski S, Cummings J, et al. Public housing relocations in Atlanta, Georgia, and declines in spatial access to safety net primary care. Health Place. 2012;18(6):1255–60.CrossRefPubMedPubMedCentral
32.
go back to reference Strathdee SA, Palepu A, Cornelisse PG, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA. 1998;280(6):547–9.CrossRefPubMed Strathdee SA, Palepu A, Cornelisse PG, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA. 1998;280(6):547–9.CrossRefPubMed
33.
go back to reference Palepu A, Tyndall MW, Joy R, et al. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend. 2006;84(2):188–94.CrossRefPubMed Palepu A, Tyndall MW, Joy R, et al. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend. 2006;84(2):188–94.CrossRefPubMed
34.
go back to reference Uhlmann S, Milloy M-J, Kerr T, et al. Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users. Addiction. 2010;105(5):907–13.CrossRefPubMedPubMedCentral Uhlmann S, Milloy M-J, Kerr T, et al. Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users. Addiction. 2010;105(5):907–13.CrossRefPubMedPubMedCentral
35.
go back to reference Sangsari S, Milloy M-J, Ibrahim A, et al. Physician experience and rates of plasma HIV-1 RNA suppression among illicit drug users: an observational study. BMC Infect Dis. 2012;12(1):22.CrossRefPubMedPubMedCentral Sangsari S, Milloy M-J, Ibrahim A, et al. Physician experience and rates of plasma HIV-1 RNA suppression among illicit drug users: an observational study. BMC Infect Dis. 2012;12(1):22.CrossRefPubMedPubMedCentral
36.
go back to reference Wood E, Montaner JSG, Yip B, et al. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ. 2003;169(7):656–61.PubMedPubMedCentral Wood E, Montaner JSG, Yip B, et al. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ. 2003;169(7):656–61.PubMedPubMedCentral
37.
go back to reference Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol. 1993;138(11):923–36.PubMed Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol. 1993;138(11):923–36.PubMed
38.
go back to reference Ti L, Milloy M-J, Shannon K, et al. Suboptimal plasma HIV-1 RNA suppression and adherence among sex workers who use illicit drugs in a Canadian setting: an observational cohort study. Sex Transm Infect. 2014;90(5):418–22.CrossRefPubMedPubMedCentral Ti L, Milloy M-J, Shannon K, et al. Suboptimal plasma HIV-1 RNA suppression and adherence among sex workers who use illicit drugs in a Canadian setting: an observational cohort study. Sex Transm Infect. 2014;90(5):418–22.CrossRefPubMedPubMedCentral
39.
go back to reference Bangsberg D, Tulsky JP, Hecht FM, Moss AR. Protease inhibitors in the homeless. JAMA. 1997;278(1):63–5.CrossRefPubMed Bangsberg D, Tulsky JP, Hecht FM, Moss AR. Protease inhibitors in the homeless. JAMA. 1997;278(1):63–5.CrossRefPubMed
40.
go back to reference Scott A, Ellen J, Clum G, Leonard L. HIV and housing assistance in four U.S. cities: variations in local experience. AIDS Behav. 2007;11(6 Suppl):140–8.CrossRefPubMed Scott A, Ellen J, Clum G, Leonard L. HIV and housing assistance in four U.S. cities: variations in local experience. AIDS Behav. 2007;11(6 Suppl):140–8.CrossRefPubMed
41.
go back to reference Azar P, Wood E, Nguyen P, et al. Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis. BMC Infect Dis. 2015;15:193.CrossRefPubMedPubMedCentral Azar P, Wood E, Nguyen P, et al. Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis. BMC Infect Dis. 2015;15:193.CrossRefPubMedPubMedCentral
42.
go back to reference Thiele B. The human right to adequate housing: a tool for promoting and protecting individual and community health. Am J Public Health. 2002;92(5):712–5.CrossRefPubMedPubMedCentral Thiele B. The human right to adequate housing: a tool for promoting and protecting individual and community health. Am J Public Health. 2002;92(5):712–5.CrossRefPubMedPubMedCentral
43.
go back to reference Desmond M. Eviction and the reproduction of urban poverty. Am J Sociol. 2012;118(1):88–133.CrossRef Desmond M. Eviction and the reproduction of urban poverty. Am J Sociol. 2012;118(1):88–133.CrossRef
44.
go back to reference Wolitski RJ, Kidder DP, Pals SL, et al. Randomized trial of the effects of housing assistance on the health and risk behaviors of homeless and unstably housed people living with HIV. AIDS Behav. 2010;14(3):493–503.CrossRefPubMed Wolitski RJ, Kidder DP, Pals SL, et al. Randomized trial of the effects of housing assistance on the health and risk behaviors of homeless and unstably housed people living with HIV. AIDS Behav. 2010;14(3):493–503.CrossRefPubMed
Metadata
Title
Residential Eviction and Risk of Detectable Plasma HIV-1 RNA Viral Load Among HIV-Positive People Who Use Drugs
Authors
Mary Clare Kennedy
Thomas Kerr
Ryan McNeil
Surita Parashar
Julio Montaner
Evan Wood
M.-J. Milloy
Publication date
01-03-2017
Publisher
Springer US
Published in
AIDS and Behavior / Issue 3/2017
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-016-1315-z

Other articles of this Issue 3/2017

AIDS and Behavior 3/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.